Hims & Hers Health Registered (A) WKN: A2QMYY ISIN: US4330001060 Forum: Aktien Thema: Hauptdiskussion

Kommt gleich

Wachstum angezogen.

schmiert mal ab das ding, oder seh ich das falsch?

60 Prozent beat beim EPS

Nicht überrascht

Digga

Wieso -8%

Revenue of approximately $2.35 billion, up 59% year-over-year in 2025 Net income of $128 million; Adjusted EBITDA of $318 million in 2025 Subscribers grew to over 2.5 million, up 13% year-over-year in 2025 Provides Q1 and full year 2026 guidance1, with full year 2026 revenue in the range of $2.7 billion to $2.9 billion and Adjusted EBITDA in the range of $300 million to $375 million

Alle rein

Also ich seh -8%

$HIMS FY25 Revenue +59% Y/Y, Guides FY26 Revenue $2.7B–$2.9B • Revenue: $617.8M (+28% Y/Y) | Adj. EBITDA: $66.3M | Net income: $20.6M • FY25: Revenue $2.35B (+59% Y/Y) | Net income $128.4M | Adj. EBITDA $318.0M | Subscribers 2.51M (+13% Y/Y) • Guidance: Q1 revenue $600M–$625M | Q1 adj. EBITDA $35M–$55M | FY26 revenue $2.7B–$2.9B & adj. EBITDA $300M–$375M

Gute Zahlen

Hey Unglaublich

Zahlen sind grün

was denkst du sergej, testen wir das ath an?

Sind gut